Early initiation of disease-modifying therapy can impede or prevent diffuse myocardial fibrosis in sickle cell anemia.

Niss, Omar; Detterich, Jon; Wood, John C; Coates, Thomas D; Malik, Punam; Taylor, Michael D; Quinn, Charles T

Niss, Omar; Detterich, Jon; Wood, John C; Coates, Thomas D; Malik, Punam; Taylor, Michael D; Quinn, Charles T.

Afiliación

Niss O; Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Detterich J; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH.
Wood JC; Cardiology and.
Coates TD; Cardiology and.
Malik P; Hematology, Children's Hospital Los Angeles, Los Angeles, CA; and.
Taylor MD; Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Quinn CT; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH.

Blood ; 140(11): 1322-1324, 2022 09 15.

Article en En | MEDLINE | ID: mdl-35857896

Asunto(s)

Anemia de Células Falciformes; Cardiomiopatías; Anemia de Células Falciformes/complicaciones; Anemia de Células Falciformes/tratamiento farmacológico; Anemia de Células Falciformes/patología; Cardiomiopatías/patología; Fibrosis; Humanos; Miocardio/patología

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anemia de Células Falciformes / Cardiomiopatías Límite: Humans Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google